← Open Payments lookup

ALEXIS CEFALU: Open Payments

NPI 1740046176 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$643 in 23 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $412 · 2025 $643

Food & beverage: $643
CompanyPaymentsAmount
ABBVIE INC.9$325
Averitas Pharma Inc.2$65
Axsome Therapeutics, Inc.2$54
ARGENX US, INC.3$53
Novo Nordisk Inc1$25
Lundbeck LLC1$22
Lilly USA, LLC1$22
SK Life Science, Inc.1$21
Boehringer Ingelheim Pharmaceuticals, Inc.1$20
PFIZER INC.1$20

Products named: UBRELVY, QULIPTA, QUTENZA, Auvelity, VYVGART HYTRULO, VRAYLAR, Wegovy, REXULTI.

Industry payments across LA — which companies pay providers there.